JP2019501133A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019501133A5 JP2019501133A5 JP2018526682A JP2018526682A JP2019501133A5 JP 2019501133 A5 JP2019501133 A5 JP 2019501133A5 JP 2018526682 A JP2018526682 A JP 2018526682A JP 2018526682 A JP2018526682 A JP 2018526682A JP 2019501133 A5 JP2019501133 A5 JP 2019501133A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- formula
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C[C@](CCN(C1)C(CC#N)=O)[C@]1N(C)c1c(cc[n]2C(N(C)CCN(C)C(OCc(cc3)cc(*)c3O[C@@]([C@]([C@@]([C@@]3O)O)O)O[C@@]3C(O)=O)=O)=O)c2ncn1 Chemical compound C[C@](CCN(C1)C(CC#N)=O)[C@]1N(C)c1c(cc[n]2C(N(C)CCN(C)C(OCc(cc3)cc(*)c3O[C@@]([C@]([C@@]([C@@]3O)O)O)O[C@@]3C(O)=O)=O)=O)c2ncn1 0.000 description 6
- NKJXNCPMTBJPHR-BEFAXECRSA-N C[C@H](CCN(C1)C(CC#N)=O)[C@H]1N(C)c1ncnc2c1cc[n]2C(Oc(cc1)ccc1[N+]([O-])=O)=O Chemical compound C[C@H](CCN(C1)C(CC#N)=O)[C@H]1N(C)c1ncnc2c1cc[n]2C(Oc(cc1)ccc1[N+]([O-])=O)=O NKJXNCPMTBJPHR-BEFAXECRSA-N 0.000 description 4
- UJLAWZDWDVHWOW-YPMHNXCESA-N C[C@H](CCN(C1)C(CC#N)=O)[C@H]1N(C)c1c(cc[nH]2)c2ncn1 Chemical compound C[C@H](CCN(C1)C(CC#N)=O)[C@H]1N(C)c1c(cc[nH]2)c2ncn1 UJLAWZDWDVHWOW-YPMHNXCESA-N 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562259273P | 2015-11-24 | 2015-11-24 | |
| US62/259,273 | 2015-11-24 | ||
| PCT/US2016/063254 WO2017091544A1 (en) | 2015-11-24 | 2016-11-22 | Prodrugs of a jak inhibitor compound for treatment of gastrointestinal inflammatory disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020141651A Division JP2020196742A (ja) | 2015-11-24 | 2020-08-25 | 胃腸炎症性腸疾患の処置のための、ｊａｋ阻害剤化合物のプロドラッグ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019501133A JP2019501133A (ja) | 2019-01-17 |
| JP2019501133A5 true JP2019501133A5 (enExample) | 2019-11-14 |
| JP6778747B2 JP6778747B2 (ja) | 2020-11-04 |
Family
ID=57518004
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018526682A Active JP6778747B2 (ja) | 2015-11-24 | 2016-11-22 | 胃腸炎症性腸疾患の処置のための、ｊａｋ阻害剤化合物のプロドラッグ |
| JP2020141651A Pending JP2020196742A (ja) | 2015-11-24 | 2020-08-25 | 胃腸炎症性腸疾患の処置のための、ｊａｋ阻害剤化合物のプロドラッグ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020141651A Pending JP2020196742A (ja) | 2015-11-24 | 2020-08-25 | 胃腸炎症性腸疾患の処置のための、ｊａｋ阻害剤化合物のプロドラッグ |
Country Status (33)
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3831830A1 (en) | 2015-11-03 | 2021-06-09 | Topivert Pharma Limited | 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as janus kinase inhibitors |
| DK3712152T3 (da) | 2015-11-03 | 2021-03-22 | Topivert Pharma Ltd | 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridin og 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepinderivater som janus kinase-inhibitorer |
| CA3003283A1 (en) | 2015-11-24 | 2017-06-01 | Theravance Biopharma R&D Ip, Llc | Prodrugs of a jak inhibitor compound for treatment of gastrointestinal inflammatory disease |
| FR3060567B1 (fr) * | 2016-12-19 | 2019-05-24 | Ecole Normale Superieure De Lyon | Substrat de glycosidase fluorogene et procede de detection associe |
| CN110418796A (zh) | 2017-03-08 | 2019-11-05 | 施万生物制药研发Ip有限责任公司 | 托法替尼(tofacitinib)的葡萄糖苷酸前药 |
| EP3609903A1 (en) * | 2017-05-23 | 2020-02-19 | Theravance Biopharma R&D IP, LLC | Thiocarbamate prodrugs of tofacitinib |
| BR112019024509A2 (pt) | 2017-05-23 | 2020-06-23 | Theravance Biopharma R&D Ip, Llc | Glicuronídeo de pró-fármacos dos inibidores da janus quinase |
| CN110869024A (zh) * | 2017-06-05 | 2020-03-06 | 旗舰创业创新五公司 | 多生物剂及其使用方法 |
| AU2019205325A1 (en) | 2018-01-05 | 2020-08-13 | Cybrexa 1, Inc. | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues |
| KR20190110459A (ko) * | 2018-03-20 | 2019-09-30 | 삼진제약주식회사 | 신규 염, 이의 제조 방법 및 이를 포함하는 약학 조성물 |
| US12171764B2 (en) | 2018-06-20 | 2024-12-24 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor |
| CN111094314B (zh) * | 2018-08-15 | 2022-08-12 | 江苏豪森药业集团有限公司 | 含有葡糖苷酸衍生物jak抑制剂的前药及其制备方法和应用 |
| EP3847158B1 (en) * | 2018-09-06 | 2026-06-24 | Arena Pharmaceuticals, Inc. | Compounds useful in the treatment of autoimmune and inflammatory disorders |
| CN109134564B (zh) * | 2018-09-21 | 2022-03-11 | 合肥锐思生物医药有限公司 | 乳果糖糖苷衍生物、其制备方法及其用途 |
| CA3119294A1 (en) * | 2018-11-15 | 2020-05-22 | Janssen Biotech, Inc. | Methods and compositions for prediction of response to a therapy of inflammatory bowel disease |
| US11596632B2 (en) * | 2018-12-19 | 2023-03-07 | Incyte Corporation | JAK1 pathway inhibitors for the treatment of gastrointestinal disease |
| CA3129665A1 (en) | 2019-03-21 | 2020-09-24 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| MX2022000449A (es) | 2019-07-10 | 2022-04-25 | Cybrexa 2 Inc | Conjugados peptídicos de citotoxinas como terapéuticos. |
| BR112022000297A2 (pt) | 2019-07-10 | 2022-03-15 | Cybrexa 3 Inc | Conjugados de peptídeos de agentes de alvo de microtúbulos como terapêuticos |
| KR20220098759A (ko) | 2019-11-08 | 2022-07-12 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 키나제 억제제에 대해 내성을 획득한 암의 치료 방법 |
| WO2021097074A1 (en) * | 2019-11-13 | 2021-05-20 | New York University | Intestinal organoid co-culture systems and methods for treating or preventing a disease or disorder associated with immune response-mediated tissue injury |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| WO2021174024A1 (en) * | 2020-02-28 | 2021-09-02 | First Wave Bio, Inc. | Methods of treating iatrogenic autoimmune colitis |
| TW202207918A (zh) * | 2020-05-14 | 2022-03-01 | 美商施萬生物製藥研發Ｉｐ有限責任公司 | 腸道選擇性ｊａｋ３抑制劑的投與 |
| CN113943312A (zh) * | 2020-07-17 | 2022-01-18 | 轶诺(浙江)药业有限公司 | 一类肠道裂解型共药及其制备和用途 |
| US20250325662A1 (en) * | 2020-10-22 | 2025-10-23 | Bt Bidco, Inc. | Methods of treating and predicting non-response to anti-tnf treatment in subjects with gastrointestinal tract diseases |
| EP4351584A4 (en) * | 2021-06-07 | 2025-04-23 | The Regents of the University of California | COMPOSITIONS AND METHODS FOR TREATING CELIAC DISEASE |
| KR20240027732A (ko) * | 2021-07-20 | 2024-03-04 | 코발 바이오파마 (상하이) 컴퍼니 리미티드 | 외용 항염증 결합 화합물 약물 및 그 제조 방법과 응용 |
| EP4525835A4 (en) * | 2022-05-14 | 2026-05-27 | 3 D Matrix Ltd | NEW FORMULATIONS FOR ORAL ADMINISTRATION OF THERAPEUTIC AGENTS AT THE GASTROINTESTINAL TRACT LEVEL |
| CN115073543B (zh) * | 2022-07-20 | 2022-11-15 | 北京普祺医药科技股份有限公司 | 一种jak抑制剂的化合物前药及其制备与应用 |
| CN117567460A (zh) * | 2022-08-08 | 2024-02-20 | 明慧医药（杭州）有限公司 | 一种前药化合物及其制备方法和用途 |
| AU2023326364A1 (en) | 2022-08-17 | 2025-03-06 | Transcend Therapeutics, Inc. | Phenethylamines and cathinones precursors |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993022334A1 (en) | 1992-05-04 | 1993-11-11 | Sri International | Pharmaceutical compositions and methods for colonic delivery of corticosteroids |
| US5811388A (en) | 1995-06-07 | 1998-09-22 | Cibus Pharmaceutical, Inc. | Delivery of drugs to the lower GI tract |
| OA12118A (en) | 1999-12-10 | 2006-05-04 | Pfizer Prod Inc | PyrroloÄ2,3-dÜpyrimidine compounds. |
| EA021478B1 (ru) | 2009-10-09 | 2015-06-30 | Инсайт Корпорейшн | ГИДРОКСИЛЬНЫЕ, КЕТО И ГЛЮКУРОНИДНЫЕ ПРОИЗВОДНЫЕ 3-(4-(7Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1Н-ПИРАЗОЛ-1-ИЛ)-3-ЦИКЛОПЕНТИЛПРОПАННИТРИЛА |
| EP2695617B1 (en) | 2009-12-23 | 2019-01-09 | Glycomyr Inc. | Vitamin D glycosides and sulfates for treating intestinal diseases |
| CN102724967A (zh) | 2009-12-31 | 2012-10-10 | 安龙制药公司 | 包括可释放的脲连接体的含芳香胺化合物的聚合缀合物 |
| AU2011213198B2 (en) * | 2010-02-05 | 2014-04-24 | Zoetis Llc | Pyrrolo [ 2,3-d] pyrimidine urea compounds as JAK inhibitors |
| US20130109720A1 (en) | 2011-11-01 | 2013-05-02 | Hoffmann-La Roche Inc. | Indole inhibitors of crac |
| US20140357557A1 (en) * | 2013-05-31 | 2014-12-04 | Cerulean Pharma Inc. | Cyclodextrin-based polymers for therapeutic delivery |
| EP3169348B1 (en) * | 2014-06-24 | 2019-07-31 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Pharmaceutical compositions comprising agonists of orexin-1 receptor ox1r for the treatment of inflammatory bowel diseases |
| CA3003283A1 (en) | 2015-11-24 | 2017-06-01 | Theravance Biopharma R&D Ip, Llc | Prodrugs of a jak inhibitor compound for treatment of gastrointestinal inflammatory disease |
| ES2954596T3 (es) | 2015-12-23 | 2023-11-23 | Univ British Columbia | Profármacos unidos a lípidos |
| CN106496233B (zh) | 2016-09-26 | 2018-05-15 | 东南大学 | 吡咯并嘧啶类化合物、其制备方法及其用途 |
-
2016
- 2016-11-22 CA CA3003283A patent/CA3003283A1/en not_active Abandoned
- 2016-11-22 CN CN201680068165.XA patent/CN108290918B/zh active Active
- 2016-11-22 TW TW105138180A patent/TWI703147B/zh not_active IP Right Cessation
- 2016-11-22 EA EA201891248A patent/EA035816B1/ru unknown
- 2016-11-22 SI SI201630741T patent/SI3380486T1/sl unknown
- 2016-11-22 UA UAA201806963A patent/UA121270C2/uk unknown
- 2016-11-22 RS RS20200508A patent/RS60237B1/sr unknown
- 2016-11-22 PL PL16808876T patent/PL3380486T3/pl unknown
- 2016-11-22 MY MYPI2018701637A patent/MY189979A/en unknown
- 2016-11-22 JP JP2018526682A patent/JP6778747B2/ja active Active
- 2016-11-22 AU AU2016359494A patent/AU2016359494B2/en not_active Ceased
- 2016-11-22 DK DK16808876.3T patent/DK3380486T3/da active
- 2016-11-22 US US15/358,462 patent/US10435428B2/en active Active
- 2016-11-22 EP EP16808876.3A patent/EP3380486B1/en active Active
- 2016-11-22 LT LTEP16808876.3T patent/LT3380486T/lt unknown
- 2016-11-22 BR BR112018010650A patent/BR112018010650A8/pt not_active IP Right Cessation
- 2016-11-22 HR HRP20200561TT patent/HRP20200561T1/hr unknown
- 2016-11-22 NZ NZ742574A patent/NZ742574A/en not_active IP Right Cessation
- 2016-11-22 PT PT168088763T patent/PT3380486T/pt unknown
- 2016-11-22 KR KR1020187017879A patent/KR20180080330A/ko not_active Withdrawn
- 2016-11-22 ME MEP-2020-126A patent/ME03757B/me unknown
- 2016-11-22 ES ES16808876T patent/ES2784523T3/es active Active
- 2016-11-22 SG SG11201803686UA patent/SG11201803686UA/en unknown
- 2016-11-22 WO PCT/US2016/063254 patent/WO2017091544A1/en not_active Ceased
- 2016-11-22 MX MX2018006282A patent/MX383107B/es unknown
- 2016-11-22 SM SM20200242T patent/SMT202000242T1/it unknown
- 2016-11-22 HU HUE16808876A patent/HUE049775T2/hu unknown
-
2018
- 2018-05-01 IL IL259076A patent/IL259076B/en active IP Right Grant
- 2018-05-07 ZA ZA2018/02967A patent/ZA201802967B/en unknown
- 2018-05-15 PH PH12018501037A patent/PH12018501037A1/en unknown
- 2018-05-18 CL CL2018001345A patent/CL2018001345A1/es unknown
- 2018-05-22 CO CONC2018/0005327A patent/CO2018005327A2/es unknown
-
2019
- 2019-08-29 US US16/555,222 patent/US10961267B2/en active Active
-
2020
- 2020-05-13 CY CY20201100447T patent/CY1122918T1/el unknown
- 2020-08-25 JP JP2020141651A patent/JP2020196742A/ja active Pending
-
2021
- 2021-02-22 US US17/249,126 patent/US11608354B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6716785B2 (ja) | Ｈｉｖウイルス感染症の予防的または治療的処置に有用な治療用化合物 | |
| CN107207498B (zh) | 用于治疗hiv的稠合嘧啶化合物 | |
| TWI649308B (zh) | 喹啉衍生物 | |
| JP2014511892A5 (enExample) | ||
| KR20170039275A (ko) | 인플루엔자 바이러스 감염에 사용하기 위한 인돌 | |
| HRP20200561T1 (hr) | Prolijekovi spoja jak inhibitora za liječenje gastrointestinalnih upalnih bolesti | |
| TW201927771A (zh) | 可作為蛋白質調節劑之雜環醯胺及其使用方法 | |
| JP2012524056A5 (enExample) | ||
| JP2015511638A5 (enExample) | ||
| JP2017518334A5 (enExample) | ||
| KR20180021730A (ko) | 티로신 키나제 억제제 | |
| JP2019500387A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| JP2014511891A5 (enExample) | ||
| JP2013544846A5 (enExample) | ||
| JP2013542261A5 (enExample) | ||
| JP2016506962A5 (enExample) | ||
| JP2017526677A5 (enExample) | ||
| JP2013510123A5 (enExample) | ||
| JP2017531619A5 (enExample) | ||
| JP2014513110A5 (enExample) | ||
| JP2024111292A (ja) | リン脂質化合物及びその使用 | |
| NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| JP2018537535A5 (enExample) | ||
| ES2797900T3 (es) | Compuestos y combinaciones para el tratamiento del VIH |